Introduction
The Tele-consultation product of company Healthlift Private Limited is called OPDlift and it is available from 2019. The solution providers value cost reduction the most. Their business model is B2B, and also has the option of white labelling the product. They provide both mobile and web based applications for the doctors. They also provide mobile applications for patient portals.
Size of Healthcare Provider
a. Individual Clinician
b. Clinics
c. Nursing Home/Small Hospital (less than 100 beds)
d. Hospital
Level of Specialization
a. Primary
b. Secondary
c. Tertiary
Expert Panel Evaluation
The solution has an easy to use interface for doctors to track and manage appointments, and inform patients about delays. Government issued UID is taken from the patient before booking an appointment. Patient gets a whatsapp message after booking an appointment (end to end whatsapp integration is there). The application is easy to use for patients. Platform has an admin role to support in managing consultation schedules. Doctor UI is simple to manage appointments, inform patients in case of delay. Call is to be initiated by the doctor, the patient can join and wait but the patient gets a blank screen while waiting. Queue management is not there for admin or doctor modules.
Doctors can interact with patients in only in the synchronous manner using chat and video/audio calling. Doctor’s mobile number and privacy is maintained. Platform has a feature that enables doctors to take an image of their handwritten prescription, preferably with the header having their details and it is shared with patients. No in-platform prescription writing facility is there, but doctors could write prescriptions on chat (Beta version at the time of demo). Previous chat and prescriptions shared (uploaded) are available on the chat interface. SMS and whatsapp messages are sent. App installation is not mandatory, compatible for both android and IoS. There is no digital signature and there is no audit trail and no recording of transactions. Patients can give feedback after consultation and payment gateway is integrated.
The solution does not support any data exchange standards and no other clinical data recording standards. Limited compliance as no drug database, and consent text is to be provided by the B2B clients which is shared with patients as text. Along with the consent text the limitations of the tele-platform based consultation are provided to the patient. Instructions to use the application are shared with patients on the registered email and whatsapp number. Patient data is protected and it is claimed to be HIPPA compliant by the solution providers.
Solution Maturity Level
a. TPG complaint: 3a
b. Feature complexity: 3b